Spero Therapeutics, Inc 10-K for FY2020
Spero Therapeutics, Inc. (SPRO)
10-K
2021-03-11
For: 2020-12-31
View Original
Added on
April 07, 2026
About this 10-K
Spero Therapeutics, Inc filed this 10-K on March 11, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.33M
- down 48.6% from $18.15M a year earlier
- Net loss
- $78.3M
- compared with a net loss of $60.9M a year earlier